Nori Wassan, Akram Wisam, Murshid Rafal Mustafa, Jaber Reia
College of Medicine, Department of Obstetrics and Gynecology, Mustansiriyah University, Baghdad, Iraq.
College of Medicine, Department of Obstetrics and Gynecology, University of Anbar, Ramadi, 31001, Iraq.
BMC Pregnancy Childbirth. 2025 Aug 30;25(1):904. doi: 10.1186/s12884-025-08080-3.
BACKGROUND: Preterm birth (PTB) is a multifactorial pathology that raises feto-maternal morbidity. Infection was associated with higher PTB risk. Earlier studies discussed the inconsistent role of Chlamydia trachomatis (CT) with PTB. To examine the contribution of CT to the overall incidence of PL in our population and to verify the concurrent impact of bacterial vaginosis (BV) on PTB risk. METHODS: A prospective cohort study enrolled low-risk pregnant women attending an antenatal clinic at a gestational age of 24-28 weeks. They were screened for CT and BV using cervical smears and subdivided into two groups: positive CT cases (study group; N = 79) and negative CT cases (control group; N = 235). They were followed until delivery. For each, maternal parameters [Maternal age, parity, socioeconomic class, BV, preterm labor, tocolytic, progestogen drugs, and dexamethasone] and Fetal parameters [Gestational age at delivery, fetal birth weight, admission to intensive care unit for respiratory distress syndrome] were recorded. RESULTS: Positive CT cases had significantly higher PBT; 20/79 (25.3%) vs. 21/235 (9%) among negative CT cases. Stratifying PTB results according to infection status revealed that 6.3% (12/189) of PTB cases were negative for both CT and BV, 12.2% (5/41) had CT alone, and 19.6% (9/46) were positive for BV alone. 39.5% (15/38) of PTB cases screened positive for CT and BV, thus highlighting a potential synergistic effect between the infection and PTB risk. Positive CT cases had higher BV incidence; 38/79 (48.1%), and higher use of tocolytic; 21/79 (26.6%), progestogen; 20/79 (25.3%), and dexamethasone drugs; 24/79 (30.4%); (P = 0.03, 0.006, 0.02, 0.009, and 0.01, respectively). Multiple logistic regression showed that positive BV cases had an increased risk of adverse outcomes, OR = 3.78. Overall model fit confirmed CT contribution to overall PTB 3-7%. Cochran-Mantel-Haenszel test discussed a BV synergistic role in PTB; OR = 2.55; 95%CI:1.44 to 4.51; P = 0.002. CONCLUSION: The current findings suggest that CT infection, especially when combined with BV, may significantly increase the risk of PTB even when both infections are appropriately treated during pregnancy. The observed synergistic interaction highlights the potential role of screening for co-infection during pregnancy and reinforces an integrated management approach beyond treatment.
背景:早产(PTB)是一种多因素病理状况,会增加母婴发病率。感染与较高的早产风险相关。早期研究探讨了沙眼衣原体(CT)在早产中作用的不一致性。本研究旨在探讨CT对我们人群中早产总体发生率的影响,并验证细菌性阴道病(BV)对早产风险的协同影响。 方法:一项前瞻性队列研究纳入了孕24 - 28周在产前诊所就诊的低风险孕妇。采用宫颈涂片对她们进行CT和BV筛查,并分为两组:CT阳性病例(研究组;N = 79)和CT阴性病例(对照组;N = 235)。对她们进行随访直至分娩。记录每位孕妇的母体参数[母亲年龄、产次、社会经济阶层、BV、早产临产、宫缩抑制剂、孕激素药物和地塞米松]以及胎儿参数[分娩时的孕周、胎儿出生体重、因呼吸窘迫综合征入住重症监护病房情况]。 结果:CT阳性病例的早产发生率显著更高;CT阳性病例中为20/79(25.3%),而CT阴性病例中为21/235(9%)。根据感染状态对早产结果进行分层显示,6.3%(12/189)的早产病例CT和BV均为阴性,12.2%(5/41)仅CT阳性,19.6%(9/46)仅BV阳性。39.5%(15/38)的早产病例CT和BV筛查均为阳性,从而突出了感染与早产风险之间潜在的协同效应。CT阳性病例的BV发生率更高;为38/79(48.1%),宫缩抑制剂的使用频率更高;为21/79(26.6%),孕激素;为20/79(25.3%),以及地塞米松药物;为24/79(30.4%);(P分别为0.03、0.006、0.02、0.009和0.01)。多因素逻辑回归显示,BV阳性病例不良结局风险增加,OR = 3.78。总体模型拟合证实CT对总体早产的贡献率为3 - 7%。 Cochr an - Mantel - Haenszel检验探讨了BV在早产中的协同作用;OR = 2.55;95%CI:1.44至4.51;P = 0.002。 结论:当前研究结果表明,CT感染,尤其是与BV合并感染时,即使在孕期对两种感染都进行了适当治疗,仍可能显著增加早产风险。观察到的协同相互作用突出了孕期筛查合并感染的潜在作用,并强化了超越治疗的综合管理方法。
Eur J Obstet Gynecol Reprod Biol. 2023-10
Cochrane Database Syst Rev. 2013-1-31
Evid Rep Technol Assess (Full Rep). 2009-3
Cochrane Database Syst Rev. 2010-3-17
Cochrane Database Syst Rev. 2022-12-1
Cochrane Database Syst Rev. 2015-1-26
Cochrane Database Syst Rev. 2015-6-20
Cochrane Database Syst Rev. 2015-11-5
BMJ. 2024-12-10
Medicina (Kaunas). 2024-7-30
Front Cell Infect Microbiol. 2024
Medicine (Baltimore). 2024-5-17